Adsorption of pharmaceuticals and related compounds in cation-exchanged zeolites – A computational perspective

阳离子交换沸石中药物和相关化合物的吸附 â 计算视角

基本信息

项目摘要

Zeolites are porous inorganic framework materials that possess an intrinsic porosity due to the presence of channels or cavities in the crystal structure. In aluminosilicate zeolites, the negative framework charge is balanced through positively charged species, mostly protons or metal cations. Cation exchange has been established as a versatile technique to modify application-relevant properties of zeolite materials. Beyond established applications (e.g., catalysis, gas separation), zeolites could also find use in the adsorption of pharmaceuticals and related functional organic molecules, targeting applications in wastewater treatment (removal of “emerging contaminants”) or in drug delivery. So far, however, only a few experimental studies have studied cation-exchanged zeolites for these uses, and systematic insights into the impact of the cation type on the adsorption of functional organic molecules are largely lacking. In this project, atomistic simulations in the framework of dispersion-corrected density functional theory (DFT) will be used to study the interaction of pharmaceuticals and related compounds with zeolite adsorbents containing different cations. Focus will be on two large-pore zeolites of particular relevance to applications (FAU and MOR framework types), considering systems containing cations from different groups. The first part of the project will comprise a thorough validation of the DFT methodology, both in terms of preferred cation sites and adsorption energies. In the second part, the interaction between cationic zeolites and a set of “model compounds”, relatively simple pharmaceuticals containing representative functional groups, will be studied systematically, considering different cation species as well as variations in Si/Al ratio and framework type (FAU/MOR). A set of case studies will be performed in the third part: On the basis of published experimental studies, organic species of particular interest in the context of wastewater treatment or drug delivery will be identified. DFT calculations will then be employed to study their interaction with cationic zeolites, not only comparing different cation types, but also considering various additional aspect of relevance for real-world applications, such as the impact of temperature and the competitive adsorption of water. Altogether, the calculations performed in this project will lead to a better atomic-level understanding of the interactions between functional organic molecules and cationic zeolites, delivering valuable insights for the development of tailored zeolite adsorbents. While the project itself is of a purely computational nature, it is anticipated that it will stimulate more applied research activities by allowing the identification of zeolite-guest combinations that warrant a more comprehensive experimental investigation.
沸石是一种多孔性的无机骨架材料,由于晶体结构中存在孔道或空穴而具有固有的孔隙率。在铝硅酸盐沸石中,负电荷通过带正电的物种(主要是质子或金属阳离子)来平衡。阳离子交换已被确立为一种改变沸石材料应用相关性能的通用技术。除了已有的应用(如催化、气体分离)外,沸石还可用于吸附药物和相关的功能有机分子,目标是废水处理(去除“新出现的污染物”)或药物输送方面的应用。然而,到目前为止,只有几个实验研究将阳离子交换沸石用于这些用途,并且缺乏对阳离子类型对功能有机分子吸附的影响的系统的深入了解。本项目将在色散修正密度泛函理论(DFT)的框架下进行原子模拟,研究药物及其相关化合物与含不同阳离子的沸石吸附剂之间的相互作用。重点将放在两种与应用特别相关的大孔沸石上(FAU和MOR骨架类型),考虑到包含不同基团的阳离子的体系。该项目的第一部分将包括对DFT方法的彻底验证,包括首选阳离子位置和吸附能量。在第二部分中,我们将系统地研究阳离子沸石与一组相对简单的含有代表性官能团的“模型化合物”之间的相互作用,包括不同的阳离子物种以及不同的硅铝比和骨架类型(FAU/MOR)。第三部分将进行一系列案例研究:在已发表的实验研究的基础上,将确定在废水处理或药物输送方面特别感兴趣的有机物种。然后将使用密度泛函计算来研究它们与阳离子沸石的相互作用,不仅比较不同的阳离子类型,还考虑与实际应用相关的各种额外方面,如温度的影响和水的竞争吸附。总之,本项目中进行的计算将导致更好地在原子水平上了解功能有机分子与阳离子沸石之间的相互作用,为定制沸石吸附剂的开发提供有价值的见解。虽然该项目本身是纯计算性质的,但预计它将通过允许识别沸石-客体组合来刺激更多的应用研究活动,从而值得进行更全面的实验研究。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Dr. Michael Fischer其他文献

Dr. Michael Fischer的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Dr. Michael Fischer', 18)}}的其他基金

Beyond tetrahedral coordination in zeolite-type materials - A computational approach
超越沸石型材料中的四面体配位——一种计算方法
  • 批准号:
    389577027
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
    Research Grants
Gas separation in microporous materials: A computational study of the influence of structural features on the selectivity
微孔材料中的气体分离:结构特征对选择性影响的计算研究
  • 批准号:
    214172356
  • 财政年份:
    2011
  • 资助金额:
    --
  • 项目类别:
    Research Fellowships
Comparative, modelling-based investigations of pharmaceutical adsorption in zeolites
基于模型的沸石药物吸附比较研究
  • 批准号:
    455871835
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
    Heisenberg Grants
Adsorption of pharmaceuticals and personal care products in hydrophobic zeolites
疏水性沸石中药物和个人护理产品的吸附
  • 批准号:
    492604837
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
    Research Grants

相似海外基金

Bioprocess for the manufacturing of affordable pharmaceuticals to prevent and treat cancers, obesity and age-related diseases
用于生产预防和治疗癌症、肥胖症和年龄相关疾病的负担得起的药物的生物工艺
  • 批准号:
    133774
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
    Feasibility Studies
Nucleation Enhanced Crystallization of Pharmaceuticals in Continuous Flow Manufacturing to Mitigate Therapeutic Drug Shortages
在连续流程制造中成核增强药物结晶以缓解治疗药物短缺
  • 批准号:
    9137884
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
Improving Outcome in Neonatal Abstinence Syndrome
改善新生儿戒断综合症的治疗效果
  • 批准号:
    8690003
  • 财政年份:
    2012
  • 资助金额:
    --
  • 项目类别:
Improving Outcome in Neonatal Abstinence Syndrome
改善新生儿戒断综合症的治疗效果
  • 批准号:
    8537884
  • 财政年份:
    2012
  • 资助金额:
    --
  • 项目类别:
Improving Outcome in Neonatal Abstinence Syndrome
改善新生儿戒断综合症的治疗效果
  • 批准号:
    8372286
  • 财政年份:
    2012
  • 资助金额:
    --
  • 项目类别:
Nanodosing: A path to higher sensitivity and lower toxicity pharmaceuticals
纳米剂量:获得更高灵敏度和更低毒性药物的途径
  • 批准号:
    7328486
  • 财政年份:
    2007
  • 资助金额:
    --
  • 项目类别:
Nanodosing: A path to higher sensitivity and lower toxicity pharmaceuticals
纳米剂量:获得更高灵敏度和更低毒性药物的途径
  • 批准号:
    7674254
  • 财政年份:
    2007
  • 资助金额:
    --
  • 项目类别:
Nanodosing: A path to higher sensitivity and lower toxicity pharmaceuticals
纳米剂量:获得更高灵敏度和更低毒性药物的途径
  • 批准号:
    7686307
  • 财政年份:
    2007
  • 资助金额:
    --
  • 项目类别:
Pharmaceuticals and Cancer
制药与癌症
  • 批准号:
    7061811
  • 财政年份:
    2004
  • 资助金额:
    --
  • 项目类别:
Improving Drug Development for the Critically Ill Child
改善危重儿童的药物开发
  • 批准号:
    7544930
  • 财政年份:
    2004
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了